NEWS

RealSelf unveils most-loved aesthetic procedures

Aesthetic review site RealSelf has announced its 2022 “Most Worth It” honorees list, revealing what the most-loved procedures are, according to consumers.

To be recognised, a treatment needed to meet the minimum requirement of 50 reviews between January 1, 2021, and December 31, 2021, and have earned a cumulative “Worth It” rating of 90% or higher during the same time period.

The RealSelf “Worth It” rating is a proprietary consumer satisfaction score based on reviews from users of the site who, after undergoing a treatment, rated it as being “worth it” or “not worth it.”

Non-surgical options for smooth, radiant skin consistently ranked high among members, with injectable neuromodulators still the most popular procedure in this category. Dermal fillers also ranked highly, with an overall score of 93%.

Deep plane face-lifts, designed to treat drooping cheeks, along with the lower face, jawline, and neck, were clear favourites, earning a 100% Worth It rating. Forehead reduction surgery, which is designed to create a more balanced facial proportion, also scored 100%.

For the body, body lifts and mini tummy-tucks were rated highly among patients, each scoring 98% and breast surgeries continue to be popular, with more than 5,000 Worth It reviews of breastrelated procedures posted in 2021. Satisfaction with breast surgeries continued to be very high, with a 97% rating.

But it wasn’t just about enlargement, breast implant removal took home a “Most Worth It” ranking of 97%. Breast implant removal was an overarching celebrity plastic surgery trend of 2021— common reasons breast implants are removed include a desire to address health concerns, implant failure, or complications. However, some women are just ready for smaller breasts.

BCAM elects Dr Catherine Fairris as vice-president

The British College of Aesthetic Medicine (BCAM) has appointed Dr Catherine Fairris as vice-president and president-elect.

Dr Fairris, who is the trustee responsible for education and events, will work alongside BCAM president, Dr Uliana Gout, to increase public outreach, work with stakeholders on regulation issues and expand events, such as the annual conference and members’ educational brunch sessions.

She said, “I feel incredibly privileged to have been given the opportunity to take on this role. I look forward to working with the rest of the board in this new capacity to accomplish more great things for BCAM, its members and the aesthetic medicine community as a whole.”

The BCAM board has also been further strengthened by the addition of Dr Rupert Critchley, who has a keen interest in education, bringing the total number of trustees to eight.

Dr Critchley said, “It’s an absolute privilege to be selected as a trustee for BCAM. I am passionate about creating change in the UK aesthetics sector, and I believe in improving safety standards and regulations, standardising training pathways and educating responsible injectors to help this industry evolve. I look forward to joining BCAM on this exciting and important journey.”

Dr Gout, who was re-appointed president in November, said: “2021 was a phenomenal year for BCAM with so many incredible initiatives coming to fruition, so we wanted to build on the success. BCAM has assembled a fantastic team to progress its work, leading with fact, not opinion, supporting its members and educating the public. Congratulations to Dr Fairris for being voted in as vice-president, I look forward to working together, and we welcome Dr Critchley, whose expertise and enthusiasm will be a great asset to the college.”

Dr Paul Myers, who has been a BCAM trustee for many years, has stepped down to take on the role of chair of the College’s Revalidation and Appraisal Committee.

Dalvi Humzah Aesthetic Training launches ultrasound course

Consultant plastic and reconstructive surgeon Mr Dalvi Humzah has launched a new ultrasound development course under the umbrella of his training company – Dalvi Humzah Aesthetic Training.

“We are introducing a novel ultrasound course based on the principles of ‘Spaced Learning’ a technique that has been shown to enhance and enable retention of knowledge in the current technological learning systems”, he explained.

The course will enable practitioners to develop their knowledge and skills in a staged approach, including online learning, webinars, and a hands-on session where practitioners will be able to identify structures and explore in more detail the uses of ultrasound in practice.

During injectable sessions, the ultrasound scanner will be used to look at specific regions and delegates will inject under ultrasound guidance. Complications and identification of displaced products will also be examined in detail, as well as skills of using this to deal with complications.

Mr Humzah said, “The new generation of handheld ultrasounds provide a means of shining a light into the depths of tissues while injecting. This staged approach will enable practitioners to develop their knowledge and skills to an optimal level and enhance their practice in aesthetics whilst providing a safer treatment pathway for patients.”

The course will take place in the Midlands on March 2.

Lumenis to partner with children’s burns trust

Lumenis has chosen to partner with the Children’s Burns Trust as its charity for 2022.

The Lumenis UK team hopes to raise as much money as possible for the charity through a series of fundraising events that will include a social event and several sponsored sporting events to be announced throughout the year.

Research released by the Children’s Burns Trust as part of its annual National Burn Awareness Day campaign revealed that more than 8,000 children in the UK were burned or scalded in 2020 alone.

This figure only relates to the more serious burns and scalds – it does not include the thousands seen by A&E departments. The charity is dedicated to providing rehabilitation support for burned and scald injured children and their families, as well as prevention and awareness campaigns for which there is little or no national funding.

Sinclair Pharma announces The MaLi Experience

Sinclair Pharma has announced the introduction of a new style of training. The MaiLi Experience, presented by Sinclair College, provides a new touchpoint for clinicians to learn how to treat with the company’s latest innovative HA filler product.

The comprehensive training programme combines essential anatomical knowledge and key practical skills. Held monthly from March 2022, at the Royal College of General Practitioners, delegates will learn from some of Sinclair Pharma’s Leading Aesthetic Experts, including Dr Victoria Manning, Dr Charlotte Woodward, Dr Sabika Karim, Dr Leah Totton, Dr Sheila Nguyen and Dr MJ Rowland- Warmann.

Sinclair Pharma is also offering an In-Clinic Experience. This enables a practice to receive personal training for four or five clinicians at the Leading Aesthetic Expert’s clinics.

Dr Preema Vig opens private meeting and training space in London

Dr Preema Vig has opened a new private meeting and training space at her London clinic, which is available for others to hire.

The Training Suite at Dr Preema London Clinic is 310 square feet and provides a versatile space to host meetings, events, exhibitions or training sessions.

It can comfortably seat up to 14 guests in a boardroom style, 20 guests in a classroom style or 10 guests for practical training sessions.

Available Monday to Saturday in the luxurious Mayfair clinic, the Training Suite is currently available on a room-only basis.

Further practical training space is available with one of the spacious treatment rooms for hire for a small number of guests or a private training session with views overlooking Hyde Park and Park Lane.

British Skin Foundation and ITN collaborate on new programme

The British Skin Foundation and ITN are co-producing a new news-style programme taking an unfiltered look at skin across all age groups.

The Ages of our Skin will be anchored by a presenter from the ITN London Studios and will address myths and misinformation with clear, science-based advice from industry experts.

The programme will explore new developments in the world of dermatology and will highlight BSF’s role in funding research into advancements of treatment and cures.

It will also hear from those living with different skin conditions, shining a light on what more needs to be done to prevent stigma.

The show will launch at the British Association of Dermatologists’ Annual Conference on July 5, 2022, at the SEC, Glasgow. It will be supported by an extensive marketing communications campaign led by BSF and supported by ITN Productions.

3D Dermaforce press launch held at Mayfair Hotel

3D Aesthetics hosted a press launch for its latest microneedling and radiofrequency device -3D Dermaforce at the Mayfair Hotel in London.

The event was led by Roy Cowley, founder and managing director of 3D Aesthetics and Dr Jonquille Chantrey, who has recently been announced as the brand’s Key Opinion Leader.

They were joined by some of the UK’s top beauty editors from publications such as Grazia, Elle, Marie Claire and Women’s Health.

The beauty editors were welcomed with an informal and private brunch setting in the hotel’s beautiful Amarillo suite. The intimate location facilitated a focus group session.

Dr Chantrey said, “I’ve found that the patients find it more comfortable, and what I really like about the 3D Dermaforce is the unusual vacuum function; which creates an even platform for the skin so that you can account for things like skin contour, skin irregularities and skin laxity, so the radiofrequency is delivered evenly throughout.”

Croma-Pharma completed decentralised procedure for new toxin – Letybo®

Croma-Pharma has announced that the decentralised procedure for Letybo® to gain market authorisation in Europe has been accomplished. This important step is the basis to complete Croma’s already comprehensive portfolio.

Croma’s botulinum toxin submission in Europe is based on the data of three completed randomised, placebo-controlled phase III trials that enrolled a total of >1000 subjects in Europe and the US .1 These data confirmed the efficacy and safety of Letybo®, which will be indicated for the treatment of moderate to severe glabellar lines.

National phases to grant the market authorisation across Europe are following now.

By adding its own botulinum toxin to the already broad portfolio, Croma catapults itself to a new level within the aesthetic industry.

“We are pleased to announce that our toxin has now accomplished the decentralised procedure in Europe and will continue with the market authorisation in major European countries in the next months. With this, we will now be able to complete our portfolio to meet all the needs of our customers”, managing director Andreas Prinz said.

Croma has licensed the product from the Korean toxin producer Hugel for Europe and established a joint venture company in 2018 with Hugel in order to develop and commercialise Croma’s HA filler products together with Hugel’s botulinum toxin product in the US, Canada, Australia and New Zealand. Hugel’s botulinum toxin has been the number one toxin in South Korea for six years.

1. Mueller D, Sulovsky M, Prinz V, Cajkovsky M, Frank K. Efficacy and Safety of a Novel Neurotoxin (Letibotulinum Toxin) in the Treatment of Glabellar Lines -3 Randomised, Double-blind, Placebo-Controlled Studies Followed by Open-label Extensions. Abstract published at 19th Aesthetic & Anti-Aging Medicine World Congress-AMWC; 2021 Sept 16-19; Monaco.

Study demonstrates high levels of patient satisfaction post preservation rhinoplasty

A study published in the February issue of Aesthetic Plastic Surgery has assessed patient satisfaction and improvement in quality of life (QoL) after preservation rhinoplasty (PR).

Overall, 58 patients (41 female and 17 male patients, mean age 32 ± 9.7 years) who were operated on between 2017 and 2021 were included in the prospective cohort singlecentre (private) study.

Patient assessment regarding their outcome was evaluated before surgery and at final follow-up using a validated questionnaire (Rhinoplasty Outcomes Evaluation Questionnaire = ROE). Subgroup analyses were performed between the ROE questions and radiological analysis by using the cone-beam computed tomography (CT) before surgery and at final follow-up.

After a mean follow-up of 19.7 ± 7.9 months (range = 1-50 months), a high overall patient satisfaction was observed (37.9 ± 9.2 vs. 81.25 ± 14.17, p < 0.0001). Subgroup analysis showed the highest improvement in nose appearance, breathing, and selfconfidence after surgery. The improvement of subjective breathing (1.471 ± 0.90 vs. 3.1 ± 0.88; p<0.0001) goes in line with an overall improved internal nasal valve (INV) angle (19.88° ± 3.3° vs. 22.04° ± 4.1°, p = 0.0231).

Stergiou G, Schweigler A, Finocchi V, Fortuny CG, Saban Y, Tremp M. Quality of Life (QoL) and Outcome After Preservation Rhinoplasty (PR) Using the Rhinoplasty Outcome Evaluation (ROE) Questionnaire-A Prospective Observational Single-Centre Study. Aesthetic Plast Surg. 2022 February 15. doi: 10.1007/s00266-022-02773-2. Epub ahead of print. PMID: 35169915.